Naoko Ueda-Arakawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Naoko Ueda-Arakawa has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Akitaka Tsujikawa
Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
3 shared publications - Atsushi Takahashi
Kibi International University
3 shared publications - Hideki Koizumi
Department of Ophthalmology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan
3 shared publications Moeko Kawai
Department of Ophthalmology, Tokyo Women's Medical University, Tokyo, Japan
3 shared publications- Ruka Maruko
Department of Ophthalmology, Tokyo Women's Medical University, Tokyo, Japan
3 shared publications Taiji Sakamoto
Department of Ophthalmology, Kagoshima University, Kagoshima, Japan
3 shared publications
Latest Publications
- 29 September 2026
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 48 (8) , 385-387
High Prevalence of Anti-GD2 Immunotherapy-Associated Ocular Adverse Effects Following Allogeneic HCT for Neuroblastoma
Background: GD2 is also expressed in normal ocular structures; however, much remains unknown about the risk factors for ocular adverse effects AEs following anti-GD2 immunotherapy remain unknown. Observations: We retrospectively analyzed risk factors for ocular AEs in 9 high-risk neuroblastoma patients. One of the 6 patients who underwent autologous hematopoietic cell transplantation (HCT) alone developed ocular AEs, whereas all 3 patients undergoing tandem autologous-allogeneic HCT did. Other variables, including age, history of anti-GD2 immunotherapy, and preimmunotherapy disease status, showed no significant association with ocular AEs. Conclusions: Allogeneic HCT before anti-GD2 immunotherapy may be a risk factor for ocular AEs.
- 29 September 2026
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 48 (8) , 385-387
High Prevalence of Anti-GD2 Immunotherapy-Associated Ocular Adverse Effects Following Allogeneic HCT for Neuroblastoma
Background: GD2 is also expressed in normal ocular structures; however, much remains unknown about the risk factors for ocular adverse effects AEs following anti-GD2 immunotherapy remain unknown. Observations: We retrospectively analyzed risk factors for ocular AEs in 9 high-risk neuroblastoma patients. One of the 6 patients who underwent autologous hematopoietic cell transplantation (HCT) alone developed ocular AEs, whereas all 3 patients undergoing tandem autologous-allogeneic HCT did. Other variables, including age, history of anti-GD2 immunotherapy, and preimmunotherapy disease status, showed no significant association with ocular AEs. Conclusions: Allogeneic HCT before anti-GD2 immunotherapy may be a risk factor for ocular AEs.
- 21 September 2026
- Published by Wolters Kluwer Health in Retina
ACUTE NEUROSENSORY RETINAL THINNING AND SHORT-TERM VISUAL OUTCOMES IN MASSIVE SUBMACULAR HEMORRHAGE: A LONGITUDINAL ANALYSIS FROM PRE-ONSET TO POST-DISPLACEMENT WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR
Purpose: To investigate longitudinal visual and structural changes from pre-onset to 1 month postoperatively in eyes with massive submacular hemorrhage (SMH) secondary to neovascular age-related macular degeneration (nAMD) treated with subretinal tissue plasminogen activator (tPA) injection and to identify prognostic factors for visual outcomes. Methods: This retrospective observational study reviewed the medical records of consecutive eyes with massive SMH secondary to nAMD treated with pars plana vitrectomy with subretinal tPA injection and pneumatic displacement. We assessed best-corrected visual acuity (BCVA) and foveal sensory retinal thickness (FSRT) at pre-onset, preoperative, and 1-month postoperative time points. Results: Among 74 consecutive eyes treated with subretinal tPA injection for massive SMH, we analyzed 20 eyes with available pre-onset data. FSRT decreased significantly from 193.5 ± 101.4 μm at pre-onset to 107.0 ± 59.0 μm at 1 month postoperatively ( P < 0.001). BCVA change negatively correlated with FSRT change (r = −0.56, P = 0.01). Univariable analysis showed that pre-onset BCVA significantly correlated with 1-month BCVA (r = 0.45, P = 0.049). At pre-onset, persistent fluid and pigment epithelial detachment were present in 65% and 15%, respectively. Conclusions: Massive SMH causes acute and profound neurosensory retinal thinning, and pre-onset neuronal integrity may be a key determinant of visual outcomes. Because surgery cannot reverse this immediate damage, preventing hemorrhage by maintaining a strictly fluid-free macula may be an important proactive strategy.
- 21 September 2026
- Published by Wolters Kluwer Health in Retina
ACUTE NEUROSENSORY RETINAL THINNING AND SHORT-TERM VISUAL OUTCOMES IN MASSIVE SUBMACULAR HEMORRHAGE: A LONGITUDINAL ANALYSIS FROM PRE-ONSET TO POST-DISPLACEMENT WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR
Purpose: To investigate longitudinal visual and structural changes from pre-onset to 1 month postoperatively in eyes with massive submacular hemorrhage (SMH) secondary to neovascular age-related macular degeneration (nAMD) treated with subretinal tissue plasminogen activator (tPA) injection and to identify prognostic factors for visual outcomes. Methods: This retrospective observational study reviewed the medical records of consecutive eyes with massive SMH secondary to nAMD treated with pars plana vitrectomy with subretinal tPA injection and pneumatic displacement. We assessed best-corrected visual acuity (BCVA) and foveal sensory retinal thickness (FSRT) at pre-onset, preoperative, and 1-month postoperative time points. Results: Among 74 consecutive eyes treated with subretinal tPA injection for massive SMH, we analyzed 20 eyes with available pre-onset data. FSRT decreased significantly from 193.5 ± 101.4 μm at pre-onset to 107.0 ± 59.0 μm at 1 month postoperatively ( P < 0.001). BCVA change negatively correlated with FSRT change (r = −0.56, P = 0.01). Univariable analysis showed that pre-onset BCVA significantly correlated with 1-month BCVA (r = 0.45, P = 0.049). At pre-onset, persistent fluid and pigment epithelial detachment were present in 65% and 15%, respectively. Conclusions: Massive SMH causes acute and profound neurosensory retinal thinning, and pre-onset neuronal integrity may be a key determinant of visual outcomes. Because surgery cannot reverse this immediate damage, preventing hemorrhage by maintaining a strictly fluid-free macula may be an important proactive strategy.
- Open Access
- 28 October 2025
- Published by Elsevier in Ophthalmology Science
- Vol. 6 (2) , 100984
Impact of Reticular Pseudodrusen on Clinical and Ocular Characteristics and Progression Rate of Geographic Atrophy in Japanese Patients
- 28 October 2025
- Published by Elsevier in Ophthalmology Science
- Vol. 6 (2) , 100984
Open AccessImpact of Reticular Pseudodrusen on Clinical and Ocular Characteristics and Progression Rate of Geographic Atrophy in Japanese Patients
- Open Access
- 10 April 2024
- Published by Elsevier in Ophthalmology Science
- Vol. 4 (5) , 100528
Clinical Characteristics and Progression of Pachychoroid and Conventional Geographic Atrophy
- 10 April 2024
- Published by Elsevier in Ophthalmology Science
- Vol. 4 (5) , 100528
Open AccessClinical Characteristics and Progression of Pachychoroid and Conventional Geographic Atrophy
- Open Access
- 10 June 2023
- Published by Elsevier in Ophthalmology Retina
- Vol. 7 (10) , 901-909
Clinical Characteristics and Progression of Geographic Atrophy in a Japanese Population
- 10 June 2023
- Published by Elsevier in Ophthalmology Retina
- Vol. 7 (10) , 901-909
Open AccessClinical Characteristics and Progression of Geographic Atrophy in a Japanese Population
- 1 April 2011
- Vol. 115 (4) , 391-7
[A case of non-atherothrombotic cerebroretinal small vessel disease].
There is an increasing interest in the relation between retinal artery abnormalities and cerebral small-vessel diseases (SVD), because retinal vessels share common properties with cerebral small vessels. We report a case of juvenile cerebrovascular disease presenting retinal vessel abnormalities, which clinically resembled cerebral autosomal dominant arteriopathy with stroke and ischemic leukoencephalopathy (CADASIL) but in which Notch3 gene mutations were not detected. A 42-year old woman was hospitalized at the department of Neurology in our hospital, complaining of headache and dysarthria. MRI showed bilateral spotted white matter lesions in the paraventricular area and the temporal lobe, and an ovoid lesion in the right corona radiata. Despite steroid pulse therapy, she developed right incomplete hemiparesis and new lesions were detected in the anterior temporal pole and external capsule. Her genetic analysis showed no mutations in the Notch 3 gene. Ophthalmological examination revealed arterial sheathing in the peripapillary region. Fluorescein angiography showed narrowing of the retinal arterioles and distinguished a peripheral vascular network. In this case, ophthalmological examination revealed retinal vessel abnormalities in a relatively young woman with no risk factors such as hypertention or artheriosclerosis, presenting recurrent subcortical strokes. This actual case indicates the association between retinal vessel abnormalities and cerebral SVDs.
- 1 April 2011
- Vol. 115 (4) , 391-7
[A case of non-atherothrombotic cerebroretinal small vessel disease].
There is an increasing interest in the relation between retinal artery abnormalities and cerebral small-vessel diseases (SVD), because retinal vessels share common properties with cerebral small vessels. We report a case of juvenile cerebrovascular disease presenting retinal vessel abnormalities, which clinically resembled cerebral autosomal dominant arteriopathy with stroke and ischemic leukoencephalopathy (CADASIL) but in which Notch3 gene mutations were not detected. A 42-year old woman was hospitalized at the department of Neurology in our hospital, complaining of headache and dysarthria. MRI showed bilateral spotted white matter lesions in the paraventricular area and the temporal lobe, and an ovoid lesion in the right corona radiata. Despite steroid pulse therapy, she developed right incomplete hemiparesis and new lesions were detected in the anterior temporal pole and external capsule. Her genetic analysis showed no mutations in the Notch 3 gene. Ophthalmological examination revealed arterial sheathing in the peripapillary region. Fluorescein angiography showed narrowing of the retinal arterioles and distinguished a peripheral vascular network. In this case, ophthalmological examination revealed retinal vessel abnormalities in a relatively young woman with no risk factors such as hypertention or artheriosclerosis, presenting recurrent subcortical strokes. This actual case indicates the association between retinal vessel abnormalities and cerebral SVDs.